KOSPI Investment Stock Picks: The First-Half Portfolio Chosen by 647 Fund Managers

코스피 투자 종목 고민하시나요...펀드매니저 647人이 뽑은 상반기 포트폴리오
Watch on YouTube ↗  |  January 14, 2026 at 07:45  |  1:16:29  |  Chesley Investment Advisory (체슬리투자자문)
Speakers
Park Se-ik — CEO, ex-Chief Strategist

Summary

Park Se-ik opens with viewer comments and investment discipline, then reviews newspaper articles on the KOSPI market. The main focus is the first-half portfolio survey of 647 fund managers, which favors Samsung Electronics, SK hynix, power equipment, Hive, NAVER, and select biotech names while avoiding EV batteries and some crowded shipbuilding, nuclear, and financial names. Other topics include defense stocks, Hyundai Motor's robot-driven re-rating, KOSPI target upgrades, and a warning against inverse ETFs.

  • KOSPI market cap grew over KRW 1,700tn in a year, led by Samsung Electronics and SK hynix.
  • Fund manager survey top expansions included SK hynix, Samsung Electronics, Hive, NAVER, and power equipment names.
  • Bio names Alteogen, ABL Bio, and Samsung Biologics drew interest amid government funding support.
  • EV battery, shipbuilding, nuclear, and some financial names were cited for reduction.
  • Defense stocks rallied on global arms-race and U.S. budget expansion themes.
  • Hyundai Motor drew a bullish target on robotics, hybrids, and FX benefits, with moving-average risk control.
  • The speaker warned against KOSPI inverse ETFs while saying covered call ETFs can help in choppy markets.
  • SK Securities raised its KOSPI band and recommended buying earnings-related dips.
Ideas
Park Se-ik CEO, ex-Chief Strategist 31:27
Use 5-month average for gold miners
Gold and gold mining ETFs have already risen a lot, so rather than making a fresh directional call, the speaker recommends trend management: sell if the 5-month moving average breaks and buy back on recovery; on daily charts use the 120-day or 100-day line.
Park Se-ik CEO, ex-Chief Strategist 42:36
AI memory upcycle favors Samsung, SK hynix
The global AI buildout is driving a memory semiconductor upcycle, with memory prices surging, earnings estimates being revised sharply higher, and fund managers planning to expand exposure. In the survey, SK hynix was the top pick with 199 managers and Samsung Electronics was second with 179, while the two already account for 36% of KOSPI market cap, so they remain the core KOSPI leadership trade.
Park Se-ik CEO, ex-Chief Strategist 44:49
AI data centers lift Korean power equipment
AI data center growth is sharply increasing electricity demand, while aging grids need replacement and Korean transformer and equipment makers are gaining global share. Korean policy plans include HVDC, large substations, and a 620 km West Sea submarine transmission link, and fund managers are expanding KEPCO, Hyosung Heavy Industries, and LS Electric.
Park Se-ik CEO, ex-Chief Strategist 47:45
BTS comeback drives Hive record profit
Hive is the third-most expanded fund manager pick because BTS is expected to return as a full group in 2026, which should drive record operating profit after two down years. Its non-manufacturing, tariff-light profile also reduces trade-war risk.
Park Se-ik CEO, ex-Chief Strategist 48:00
NAVER is tariff-light AI and crypto play
NAVER is a tariff-light non-manufacturing pick with AI and crypto optionality: participation in government AI and GPU infrastructure, expected AI cloud project wins, generative AI advertising solutions, and the Dunamu merger and stablecoin opportunity could create more than KRW 1tn in annual operating profit.
Park Se-ik CEO, ex-Chief Strategist 50:46
Korean biotech revival gets government support
Korean biotech is seen as reviving as government capital support expands, including a KRW 150tn National Growth Fund over five years and a KRW 150bn phase-3 clinical fund, while fund managers are increasing exposure to several bio names.
Park Se-ik CEO, ex-Chief Strategist 51:32
Alteogen leads on licensing deal pipeline
Alteogen is highlighted as a representative Korean bio pick with more than ten material transfer and licensing deals, giving it a distinct pipeline and royalty edge as bio fund flows return.
Park Se-ik CEO, ex-Chief Strategist 51:43
ABL Bio advances ADC cancer platform
ABL Bio is positioned in the antibody-drug conjugate market, combining antibodies with cytotoxic drugs to target specific cancer cells, and is advancing next-generation modality development. It received 19 fund manager expansion votes.
Park Se-ik CEO, ex-Chief Strategist 52:15
Samsung Biologics growth supported by capacity
Samsung Biologics is a fund manager favorite with 2025 operating profit up 56% and expected 20%+ growth in 2026. Capacity ramp-up, the GSK U.S. biopharma production facility acquired at end-2025, and resilient demand despite tariff concerns support the outlook.
Park Se-ik CEO, ex-Chief Strategist 53:04
EV demand cuts hurt Korean battery stocks
Fund managers are reducing Korean secondary battery names because global automakers are revising EV plans and canceling or shrinking supply contracts with Korean battery makers, leaving investment sentiment cold.
Park Se-ik CEO, ex-Chief Strategist 53:36
Fade crowded shipbuilding, nuclear leaders
Fund managers plan to reduce shipbuilding, defense, and nuclear leaders that led last year's market, citing poor evaluations and crowded positioning after their strong run. Named reductions include Doosan Enerbility, Hanwha Ocean, HD Hyundai Heavy Industries, and Samsung Heavy Industries.
Park Se-ik CEO, ex-Chief Strategist 53:52
Prefer KB, Shinhan over securities financials
Within financials, fund managers favor KB Financial and Shinhan Financial for stable earnings and dividends, while reducing Woori Financial, Mirae Asset Securities, and Meritz Financial because recent financial results were so strong that base effects are burdensome.
Park Se-ik CEO, ex-Chief Strategist 53:52
Prefer KB, Shinhan over securities financials
Within financials, fund managers favor KB Financial and Shinhan Financial for stable earnings and dividends, while reducing Woori Financial, Mirae Asset Securities, and Meritz Financial because recent financial results were so strong that base effects are burdensome.
Park Se-ik CEO, ex-Chief Strategist 60:21
Defense demand up on global arms race
Defense stocks are rallying as Trump's assertive dollarism and Monroe Doctrine-style foreign policy and a proposed 50%+ increase in the U.S. defense budget to USD 1.5tn drive global defense demand. Geopolitical tensions and arms-race dynamics support mid-to-long-term defense sector attention, though short-term volatility may rise after the rally.
Park Se-ik CEO, ex-Chief Strategist 64:51
Hyundai re-rates on robotics and hybrids
Hyundai Motor is re-rating on CES 2026 robot leadership, the Atlas humanoid robot and Nvidia collaboration, its hybrid strategy, and won weakness; it remains cheap versus Toyota. The speaker advises long-term accumulation while using the 5-month moving average for short-term risk management, and warns not to blindly chase like the 2021 Apple Car episode unless earnings actually surge.
Park Se-ik CEO, ex-Chief Strategist 70:38
Covered call ETFs cushion choppy markets
If the index stalls or chops sideways, covered call ETFs can be preferable because option premium income cushions downside and provides distributions, though they participate only partially in upside.
Park Se-ik CEO, ex-Chief Strategist 71:19
Avoid inverse bets on rising KOSPI
Retail investors have been buying KOSPI inverse and double-inverse ETFs on overheating fears, but the speaker's principle is not to bet on falling markets. Raising cash when the market is overheated is acceptable, but inverse and short bets are poor mentally and return-wise.
Park Se-ik CEO, ex-Chief Strategist 72:04
KOSPI upside remains; buy dips
SK Securities raised the KOSPI band to 4,800-5,250 and sees 2026 operating profit at KRW 474tn, up 56%, as AI and defense investment accelerate. The cited view is that Q4 earnings-driven corrections should be bought, and the speaker refuses to bet on a decline.
Up Next

This Chesley Investment Advisory (체슬리투자자문) video, published January 14, 2026, features Park Se-ik discussing GDX, 005930.KS, 000660.KS, 015760.KS, 298040.KS, 010120.KS, 267260.KS, 001440.KS, 352820.KS, 035420.KS, Korean biotech sector, 196170.KQ, 298380.KQ, 207940.KS, 373220.KS, 006400.KS, 003670.KS, 034020.KS, 042660.KS, 329180.KS, 010140.KS, 105560.KS, 055550.KS, 316140.KS, 006800.KS, 138040.KS, 012450.KS, 079550.KS, 047810.KS, 005380.KS, Covered call ETF, KOSEF, EWY. 18 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Park Se-ik  · Tickers: GDX, 005930.KS, 000660.KS, 015760.KS, 298040.KS, 010120.KS, 267260.KS, 001440.KS, 352820.KS, 035420.KS, Korean biotech sector, 196170.KQ, 298380.KQ, 207940.KS, 373220.KS, 006400.KS, 003670.KS, 034020.KS, 042660.KS, 329180.KS, 010140.KS, 105560.KS, 055550.KS, 316140.KS, 006800.KS, 138040.KS, 012450.KS, 079550.KS, 047810.KS, 005380.KS, Covered call ETF, KOSEF, EWY